Tremfya 200 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F03P3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,938
Award facts
- Contract value 100% obligated
- $22,937.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,937.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of TREMFYA 200 mg/2 mL pen injections. This non-set-aside award is scheduled for completion by February 11, 2026, with performance originating from the contractor's location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical products to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has demonstrated significant capability in fulfilling federal medical procurement requirements through competitive awards across multiple therapeutic domains. The company's extensive portfolio with the Defense Logistics Agency includes delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across oncology, diabetes management, neurological treatments, and pain management categories. This particular order for TREMFYA, a biologic immunosuppressant medication, reflects the contractor's ongoing role in supporting military treatment facilities and federal healthcare systems with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F03P3?
SPE2DR26F03P3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F03P3 worth?
The government has obligated $22,938 on SPE2DR26F03P3.
Is contract SPE2DR26F03P3 an order under another contract?
Yes. SPE2DR26F03P3 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F03P3 competed?
The extent of competition for SPE2DR26F03P3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award